New Insights into Cellular Survival Mechanisms in Nutrient-Deficient Conditions

UCLA scientists have uncovered how cells, including cancer cells, activate adaptive mechanisms involving MYC and chromatin changes to survive nutrient scarcity, opening new pathways for cancer treatment strategies.
Researchers at UCLA have revealed a remarkable strategy that cells, including cancer cells, employ to survive in environments with limited nutrients. Their study, recently published in Cancer & Metabolism, demonstrates that when amino acids—the building blocks for proteins and cell growth—are scarce, cells activate a key growth regulator called MYC. Simultaneously, they modify the chromatin structure by reducing a specific chemical mark known as H4K20me1 that typically covers active genes. These dual changes prepare the cell’s machinery for rapid protein synthesis once nutrients become available again, effectively priming the cell for recovery.
This adaptive mechanism partly explains how MYC-driven cancers, which often exhibit overactivation of the MYC gene, manage to survive and proliferate under metabolic stress. The team conducted experiments on human cells with and without amino acids, utilizing advanced molecular techniques to assess changes in gene expression and protein production. They found that reduced amino acid levels lead to a reprogramming of gene activity, especially in regions supporting protein synthesis.
Understanding this chromatin-based priming process opens new avenues for targeting cancer metabolism. By disrupting these adaptive strategies, it might be possible to develop therapies that make cancer cells more vulnerable when nutrients are scarce. Dr. Siavash Kurdistani, senior author of the study, emphasizes that recognizing how cells prepare for recovery under nutrient stress could help design new interventions for MYC-associated cancers and other diseases influenced by metabolic conditions.
This discovery highlights the resilience of cancer cells and underscores the importance of epigenetic regulation in cellular adaptation, paving the way for innovative treatments based on metabolic and chromatin remodeling mechanisms.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Cancer Immunotherapy Brings New Hope for Advanced-Stage Patients
A groundbreaking Phase II clinical trial of PRL3-zumab reveals promising results in slowing disease progression in late-stage cancer patients unresponsive to traditional therapies, offering new hope for treatment-resistant cancers.
Innovative Approach Uses Neutrophil Reprogramming to Combat Breast Cancer
A new study highlights how retraining neutrophils via innate immunity activation offers a promising therapeutic approach for difficult-to-treat breast cancers, including triple-negative subtypes.
Breakthrough in Mitochondrial Donation: Eight Healthy Babies Born Using Genetic Technology from Three People
The first eight healthy children born through mitochondrial donation in the UK mark a major scientific milestone, offering hope for families affected by genetic disorders. However, ongoing questions about safety, effectiveness, and transparency highlight the need for continued research and responsible governance.
Innovative Model Overcomes Challenges in Merging Mismatched Geographic Health Data
A new Bayesian modeling approach developed by researchers at KAUST offers a faster, more accurate way to combine mismatched geographic health and environmental datasets, advancing disease mapping and pollution analysis.



